Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Jonathan Reuning-Scherer"'
Patient-reported quality-of-life analysis of radium-223 dichloride from the phase III ALSYMPCA study
Autor:
Nicholas J. Vogelzang, Joe M. O'Sullivan, Oliver Sartor, Jonathan Reuning-Scherer, P. Cislo, Robert E. Coleman, Sten Nilsson, M. Shan, Chris Parker, L. Zhan
Publikováno v:
Annals of Oncology
In the phase III randomized ALSYMPCA trial of radium-223 in patients with castration-resistant prostate cancer and bone metastases, improved survival with radium-223 is accompanied by significant quality of life benefits, measured by EQ-5D and FACT-P
Publikováno v:
ISEE Conference Abstracts. 2017
Autor:
Ariana M. Chao, Robin Whittemore, Margaret Grey, Jonathan Reuning-Scherer, Carlos M. Grilo, Rajita Sinha
Publikováno v:
Journal of Behavioral Medicine. 39:320-332
To test whether binge eating and emotional eating mediate the relationships between self-reported stress, morning cortisol and the homeostatic model of insulin resistance and waist circumference. We also explored the moderators of gender and age. Dat
Autor:
Lars Franzén, Robert E. Coleman, David Bottomley, Oliver Sartor, Daniel Heinrich, Peter Hoskin, Sten Nilsson, Neal D. Shore, Lin Zhan, Arne Solberg, Nicholas J. Vogelzang, Joe M. O'Sullivan, Chris Parker, Jonathan Reuning-Scherer
Publikováno v:
Journal of Urology. 197
Autor:
Nicholas J. Vogelzang, Oliver Sartor, Sten Nilsson, Robert E. Coleman, Joe M. O'Sullivan, Lin Zhan, Paul Cislo, Chris Parker, Jonathan Reuning-Scherer
Publikováno v:
Parker, C, Zhan, L, Cislo, P, Reuning-Scherer, J, Vogelzang, N J, Nilsson, S, Sartor, O, O'Sullivan, J M & Coleman, R E 2017, ' Effect of radium-223 dichloride (Ra-223) on hospitalisation: An analysis from the phase 3 randomised Alpharadin in Symptomatic Prostate Cancer Patients (ALSYMPCA) trial ', European Journal of Cancer, vol. 71, pp. 1-6 . https://doi.org/10.1016/j.ejca.2016.10.020
Symptomatic skeletal events (SSEs) commonly occur in patients with bone metastases,\ud often leading to hospitalisations and decreased quality-of-life. In the ALSYMPCA trial,\ud radium-223 significantly improved overall survival (hazard ratio 0.70, 9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd84a3f444b3a7c983a971c19794b353
https://eprints.whiterose.ac.uk/110675/1/1-s2.0-S0959804916325242-main.pdf
https://eprints.whiterose.ac.uk/110675/1/1-s2.0-S0959804916325242-main.pdf
Autor:
Paulo M. Brando, Lisa M. Curran, Jennifer K. Balch, Paulo Guilherme, Jonathan Reuning-Scherer, Osvaldo Portela, Oswaldo de Carvalho, Daniel C. Nepstad
Publikováno v:
Forest Ecology and Management. 261:68-77
Anthropogenic understory fires have affected large areas of tropical forest in recent decades, particularly during severe droughts. Yet, the mechanisms that control fire-induced mortality of tropical trees and lianas remain ambiguous due to the chall
Publikováno v:
Biological Conservation. 128:147-157
Habitat fragmentation, land cover change and biodiversity loss are often associated with village communities in protected areas, but the extent and intensity of such impacts are often inadequately assessed. We record resource use and depletion by hum
Autor:
David Bottomley, Lars Franzén, Daniel Heinrich, Robert E. Coleman, A. Oliver Sartor, Sten Nilsson, Joe M. O'Sullivan, Chris Parker, Jonathan Reuning-Scherer, Peter Hoskin, Lin Zhan, Arne Solberg, Nicholas J. Vogelzang, Neal D. Shore
Publikováno v:
Journal of Clinical Oncology. 35:177-177
177 Background: Radium-223 improved overall survival (OS) with meaningful improvements vs placebo in health-related quality of life (HRQoL) in phase 3 ALSYMPCA (Parker NEJM 2013; Nilsson Ann Oncol 2016). We examined the relationship of OS to HRQoL sc
Autor:
Irving H. Gomolin, Paul F. Siami, Jonathan Reuning-Scherer, Daniel C. Haverstock, Allen Heyd, null The Oral Suspension Study Group
Publikováno v:
Journal of the American Geriatrics Society. 49:1606-1613
Publikováno v:
European Journal of Cancer. 51:S183